DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/w3q82g/2014_analysis_of) has announced the addition of the "2014 Analysis of the French Infectious Disease Testing Market: Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering.
2014 Opportunities in the French Infectious Disease Testing Market is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key French market trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests by assay, and market segment; provides test volume estimates by method (molecular, selorogy/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants.
This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies.
Microbiology testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the world's major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs.
Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.
Key Topics Covered:
II. Major Product Development Opportunities
III. Design Criteria for Decentralized Testing Products
IV. Alternative Market Penetration Strategies
V. Potential Market Entry Barriers and Risks
VI. Worldwide Overview of Major Tests,
XI. Competitive Assessments
- Beckman Coulter/Danaher
- Becton Dickinson
- Eiken Chemical
- Enzo Biochem
- ID Biomedical/GSK
- Life Technology
- Novartis Diagnostics
- Ortho-Clinical Diagnostics
- Takara Bio
- Thermo Fisher
XVI. Appendix: Assumed Currency Exchange Rates
For more information visit http://www.researchandmarkets.com/research/w3q82g/2014_analysis_of